Rod Rezaee

2PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 19, 2026
Danvatirsen plus pembrolizumab versus pembrolizumab for recurrent and/or metastatic head and neck squamous cell carcinoma (PEMDA-HN): a randomized, phase 2 trial.

|Nov 12, 2025
Long-Term Opioid Use After Treatment of Head and Neck Cancers: A Systematic Review and Meta-analysis.

Ross Rosen, John Richter, Claudia I Cabrera

Pageof 1

Frequent Collaborators

1 joint publications

Ross Rosen

1 joint publications

Daniel Karasik

1 joint publications

Shawn Li

1 joint publications

Jason Thuener